semaglutide mw Wegovy, the Weight Loss Drug,

Key Takeaways Microdosing could theoretically reduce peak-to-trough ratios by 28-38%, potentially minimizing side effects Successful precedents exist with insulin and growth hormone therapies using similar principles Mathematical models suggest maintained efficacy (~75-100%) with appropriate dose adjustments No clinical trials have validated microdosing for GLP-1 agonists - all evidence is theoretical or anecdotal 55% of microdosers make decisions without physician consultation, raising safety concerns What Is Retatrutide Microdosing

Hannay: Health Canada has a public database that shows generic drug submissions and when they were sent in (scroll down and search for semaglutide)

Sports Medicine, 43(4), pp

CCC, Canadian consensus criteria

Untreated obesity carries ongoing health risks